Exciting news on ICH GCP E6(R3) is here! Our CEO, Artem Andrianov, returned from the SCOPE Summit with updates on the updated guideline. ICH E6(R3) will incorporate technology advancements while prioritizing participant protection and reliable evidence. Don't miss Artem's thoughts on his experience at the summit. Stay tuned for more updates on ICH E6(R3)!
In an interview with Applied Clinical Trials, CEO Artem Andrianov discusses the inspiration behind the tool, its benefits to the industry, and its functionality. The tool is aimed to improve patient outcomes by reducing the risk of negative reactions to combined medications.
We are proud to announce that our Drug Interaction Visualizer has been selected as a finalist for the SCOPE Best of Show Awards. Based on real-world data from the FDA, our visualizer enables clinical research professionals to explore drug interactions and identify potential risks.
The eyesON Drug-Drug Interaction visualizer provides unique profiles of the most common adverse events and side effects of the market's most frequently prescribed and used FDA-regulated drugs.
Learn about the high failure rate of clinical trials & how the premortem approach can improve success by identifying potential problems early. Discover how this technique can foster a culture of collaboration & learning within the team, reducing the need for a painful postmortem.
At Cyntegrity, we're on a mission to deliver the highest possible data quality in clinical trials. That's why we're thrilled to have been recognized by Microsoft as a valuable use case. Don't miss out on reading how we're making a difference in the biopharma industry by checking out our customer story on Microsoft's website.
The Butterfly Challenge is a program developed by Cyntegrity that invites companies to come together and make a positive impact on the world. The program encourages collaboration and teamwork among businesses in order to create a brighter future for all.
It was a year of exciting collaborations, major accomplishments, and new beginnings at Cyntegrity. From partnering with MongoDB on The Butterfly Challenge to successfully completing SOC 2 examination and engaging over 1,200 clinical researchers through our popular mindsON workshops, we made the most of 2022. Don't miss our full recap of all that we achieved!
Discover KRI Wiki, the only Key Risk Indicator resource out there that provides a compliant by-design approach to clinical trial risk management.
IDC MarketScape has listed Cyntegrity as one of the top 8 RBQM vendors in its "Worldwide Life Science R&D Risk-Based Monitoring Solutions 2022 Vendor Assessment" study.
